BackSCIENCE_HEALTH
Can gene therapy restore hearing in children with inherited deafness? What FDA approval means
An article discusses a Regeneron gene therapy aimed at treating inherited deafness by addressing the genetic cause, rather than using assistive devices. It states the treatment would be delivered through a surgical procedure similar to cochlear implantation and explores what FDA approval would mean for this therapy.
Why It Matters
If proven effective, the therapy could shift treatment options for some inherited deafness cases from devices to a potential genetic cure.
Timeline
1 Event
FDA approval discussed and its implications for gene therapy to treat inherited deafness
April 23, 2026
The article notes a Regeneron-developed gene therapy intended to address the root genetic cause of inherited deafness in children. It states the therapy is administered through a surgical procedure similar to cochlear implantation and discusses what FDA approval would mean for such a treatment.